Search Results 531-540 of 17852 for secondary infertility
Inclusion Critieria: Subjects seeking medical care for benign reproductive disorders; Females, 18 years of age or older; Able to provide informed consent.
For the dose that meets the safety criterion in Stage 1, at least 1 response in melanoma subjects and 2 responses in TNBC subjects amongst the 12 subjects ...
The purpose of this study is to understand how electrical stimulation of the brain can modulate and suppress interictal epileptiform activity as a step on ...
Scottsdale/Phoenix, Ariz. The purpose of this study is to investigate if complete pelvic peritonectomy is associated with improved quality of life in patients ...
Your doctors and other healthcare providers use and recommend treatments based on rigorous scientific proof. However, a closer look at this "proof" ...
Patients taking any secondary GVHD therapy due to insufficient response/progression on program treatment including, but not limited to, ibrutinib ...
The subject has a confirmed diagnosis of AML, MDS, or CMML (including de novo, secondary, and therapy-related disease) according to WHO 2008 classification ...
Secondary Navigation. Overview · Application Process ... Reproductive endocrinology and infertility ... With first-year fellows, I'm very intentional with my ...
Some males who use this medicine have become infertile (unable to have children). Talk to your doctor before using this medicine if you plan to have ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!